26 - 28 November 2007, Millennium Hotel Mayfair, London, United Kingdom
New dimensions.
Register   |    Brochure   |    Sponsor   |    Email a friend   |    Add to diary


Calendar of Events
bioLOGIC Europe 2008 ~ Geneva
World Drug Safety Congress Europe ~ London
European BioPharm Scale-Up Congress 2008 ~ Geneva
Exploratory Clinical Development World Americas ~ Philadelphia
World Vaccine Congress Lyon 2008 ~ Lyon
World Vaccine Congress Australia 2008 ~ Sydney
Oncology Drug Development World Europe 2008 ~ London

More events >

                                                                                            

    Lean investment, large returns.

Adult obesity rates have almost quadrupled in the last 25 years. Now 22% of Britons are obese and three-quarters are overweight. This is a huge market, that is going to continue developing.

Obesity Drug Development World 2007 focuses on cutting edge drugs and therapies and the key commercial considerations for getting these therapies to the marketplace.  There will be learning opportunities with up-to-date case studies and roundtable brainstorming sessions. In essence, the event is scientific but also covers the commercial angle - a totally new combination. This is the only scientific and commercial obesity event out there. So if you are committed to combating obesity and furthering your business, this is the only obesity drug development event you should attend in 2007.

“Despite the significant unmet medical need of obesity, developing effective and safe therapies remains an arduous process. By covering the scientific, regulatory, and commercial aspects of obesity drug development, Obesity Drug Development World provides a valuable forum to better understand both the challenges and opportunities in this therapeutic area”

Dr Hubert Chen, Director of Clinical Research, Amylin Pharmaceuticals

> Register your place today!
> Download the conference brochure

Dr Ann Taylor
Director and Clinical Lead for Obesity Early Development
Pfizer Global R&D

Dr Douglas Green
Senior Vice President and Chief Medical Officer
sanofi aventis

Dr Matthew Coghlan
Candidate Drug Delivery Team Leader,
AstraZeneca

Pierre Honoré Vice President, Strategy and Sourcing, Diabetes Research
Novo Nordisk

Dr Gordon Brandt
Executive Vice President, Clinical Research and Medical Affairs
Nastech Pharmaceuticals

Antonio Tataranni Senior Director, Medical Acomplia
Sanofi Aventis

Extended networking at Obesity Drug Development World 2007

This is the revolutionary, exciting, quick and highly effective way to meet fellow conference delegates and industry peers in one 45 minute session. These brief meetings are the starting point for conversation and networking throughout the conference. This is where long-lasting and profitable business relationships begin. Make sure you bring plenty of business cards!

We introduce you to ‘Contact’- a system to enable you to set up meetings before the event. You can search the attendees then email them directly without ever seeing their e-mail address. The first contact is made and you can take it from there. More than just networking; Important forms and conference tips can be downloaded and after the event you can even download the white papers and presentations from our world-class speakers.

Obesity Drug Development World 2007 offers you more CEO and Director level panel discussions. There will be several “chat show” style sessions where you can get answers to your questions. You will not get a better chance than this to question the leading players in the global diabetes and obesity industry.

Capitalise on the future of the obesity and diabetes industry

Q1:  Do you target decision makers from pharmaceutical and biotech companies in the obesity industry?

Q2:  Can you provide a solution to some of the challenges that obesity and diabetes drug development companies are facing?

Q3: Can you show our delegates how to advance their drug development?

Obesity Drug Development World 2007 will cover the key commercial challenges in obesity and diabetes drug development, which take account of new therapeutic targets, bringing therapies closer to market, overcoming inactivity on the part of pharmaceutical companies, product advancement, pre-clinical and clinical trials.


Target your market!
Limited sponsorship opportunities exist for this event.

For full details contact
Ince Saleem or call +44 (0) 207 092 1323

Dr Christian Elling
Director of Molecular Pharmacology & Development
7TM Pharma

Dr Dieter Meier
Executive Vice President and Chief Medical Officer
NeuroSearch

Dr Eduardo
Dunayevich
Chief Medical Officer
Orexigen Therapeutics

Dr Hubert Chen
Director of Clinical Research
Amylin Pharmaceuticals

Dr Nigel Levens
Chief Scientific Officer
Innodia

Dr Nir Barak
Chief Scientific Officer
OBEcure
 

 
   
 

Exhibitors
Partners
Organised by